Is the price fair?
What XRAY's price assumes
Today's price asks for 5.6% free cash flow growth a year; over the last three years DENTSPLY SIRONA Inc. delivered −26%, the price is ahead of the record.
0.63
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 5.0%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +5.6%
Growth the price implies · The price pays for +5.6% free cash flow growth a year for a decade; the business has delivered −26% a year over the last three.
- Price / book
- 1.76
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 1.76
- EV / EBIToperating margin −14%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 1.12
- Free cash flow, trailing twelve months
- $104M
- Market capitalisation
- $2.07B
- 3-year revenue growth
- −2.2%
- 3-year free cash flow growth
- −26%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #27 of 27 by Smart Score